Masked hypertension (MHT), defined as nonelevated blood pressure (BP) in the clinic setting and elevated BP assessed by ambulatory monitoring, is associated with increased risk of target organ damage, cardiovascular disease, and mortality. Currently, no estimate of MHT prevalence exists for the general US population. After pooling data from the Masked Hypertension Study (n = 811), a cross-sectional clinical investigation of systematic differences between clinic BP and ambulatory BP (ABP) in a community sample of employed adults in the New York City metropolitan area (2005–2012), and the National Health and Nutrition Examination Survey (NHANES;

https://ainolehti.tumblr.com/

2005–2010; n = 9,316), an ongoing nationally representative US survey, we used multiple imputation to impute ABP-defined hypertension status for NHANES participants and estimate MHT prevalence among the 139 million US adults with nonelevated clinic BP, no history of overt cardiovascular disease, and no use of antihypertensive medication. The estimated US prevalence of MHT in 2005–2010 was 12.3% of the adult population (95% confidence interval: 10.0, 14.5)—approximately 17.1 million persons aged ?21 years.

https://catamari.tumblr.com/

Consistent with prior research, estimated MHT prevalence was higher among older persons, males, and those with prehypertension or diabetes. To our knowledge, this study provides the first estimate of US MHT prevalence—nearly 1 in 8 adults with nonelevated clinic BP—and suggests that millions of US adults may be misclassified as not having hypertension. Source: https://academic.oup.com/aje/article-abstract/185/3/194/2915788/Prevalence-of-Masked-Hypertension-Among-US-Adults

Saturday, May 30, 2026

Valtrex: Brand Name Medication Guide For Antiviral Medications

Valtrex is the brand name for valacyclovir, a medication used in the management of conditions associated with antiviral medications. Brand name medications are pharmaceutical products marketed under a proprietary name by the company that originally developed them. Understanding the relationship between brand name and generic formulations, as well as the conditions for which the medication is approved, helps patients make informed choices about their treatment. Viral infections present unique treatment challenges because viruses depend entirely on the host cell's own machinery to replicate. This close integration with human cellular processes makes designing drugs that selectively harm the virus without damaging the host cell inherently difficult. Despite these challenges, antiviral drugs have been developed for a growing number of viral diseases, and many can significantly reduce symptom severity, shorten illness duration, and prevent complications. The brand name Valtrex has built a clinical track record through use in a wide range of patients and healthcare settings. Brand versions and their generic equivalents contain the same active ingredient at the same strength, but may differ in inactive ingredients such as fillers, binders, and coatings. In most cases, generic formulations are therapeutically equivalent and offer cost savings, though some patients prefer to stay on a specific formulation for consistency. When prescribed Valtrex, patients should follow the guidance of their prescribing physician regarding dose, frequency, and duration of therapy. The medication should be stored as directed on the label, typically at room temperature away from heat and moisture. Any unused medication should not be disposed of by flushing down the drain unless the label specifically says to do so, as this can harm the environment. Comprehensive details on Valtrex and other medications used for antiviral medications are available through https://mednewwsstoday.com/antivirals/. This resource provides evidence-based summaries to help patients and healthcare providers stay informed about treatment options in this therapeutic area.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.